TELA Bio TELA
NASDAQ TELA
$0.85 -0.06 (-6.40%)
As of: Sep 10, 2026 · 1:18 PM EDT

TELA Bio (TELA) Sales of Property, Plant and Equipment (2024 - 2026)

Analysis

TELA Bio (TELA) Sales of Property, Plant and Equipment (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 180.74 Bn 175.14 Bn 7.27 Bn -
2 Intuitive Surgical 127.72 Bn 122.50 Bn 1.96 Bn -
3 Medtronic 116.88 Bn 108.06 Bn 6.34 Bn -
4 Stryker 104.10 Bn 100.62 Bn 4.50 Bn -
5 Boston Scientific 63.74 Bn 63.20 Bn 3.85 Bn -
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn -
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn -
8 Dexcom 32.15 Bn 30.20 Bn 830.00 Mn -
9 Steris 20.63 Bn 20.15 Bn 684.20 Mn -
10 TELA Bio 48.87 Mn 18.44 Mn 13.94 Mn 298,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 298,000.00
Mar 31, 2026 309,000.00
Dec 31, 2025 283,000.00
Sep 30, 2025 523,000.00
Jun 30, 2025 318,000.00
Mar 31, 2025 170,000.00
Dec 31, 2024 74,000.00
Jun 30, 2024 366,000.00
Mar 31, 2024 5.00 Mn